Chimeric Antigen Receptor T Cell Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
HGEN | F | Humanigen, Inc. | 0.00 | |
GDTC | F | CytoMed Therapeutics Limited | -3.13 | |
CRBU | F | Caribou Biosciences, Inc. | 0.39 | |
ACET | F | Adicet Bio, Inc. | 0.86 | |
NTLA | D | Intellia Therapeutics, Inc. | 1.81 | |
SNTI | D | Senti Biosciences, Inc. | -3.31 | |
PSTX | D | Poseida Therapeutics, Inc. | 3.57 | |
TSVT | D | 2seventy bio, Inc. | -0.56 | |
NKTX | D | Nkarta, Inc. | -2.48 | |
CARM | D | Carisma Therapeutics, Inc. | 1.34 |
Related Industries: Biotechnology
Related Stock Lists:
Immune System
Medicine
Biotechnology
Cancer
Biopharmaceutical
Chimeric Antigen Receptor
Clinical Medicine
Solid Tumors
Antigen
Biology
Cancer Immunotherapy
Cancer Treatment
Cell Therapy
Gene Therapy
Immunotherapy
Life Sciences
Lymphoma
Natural Killer Cell
Breakthrough Therapy
CD19
Related ETFs - A few ETFs which own one or more of the above listed Chimeric Antigen Receptor T Cell stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GNOM | D | Global X Genomics & Biotechnology ETF | 4.97 | |
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 3.91 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 3.12 | |
CNCR | C | Loncar Cancer Immunotherapy ETF | 3.03 | |
ARKK | C | ARK Innovation ETF | 2.75 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Immune System
Medicine
Biotechnology
Cancer
Biopharmaceutical
Chimeric Antigen Receptor
Clinical Medicine
Solid Tumors
Antigen
Biology
Cancer Immunotherapy
Cancer Treatment
Cell Therapy
Gene Therapy
Immunotherapy
Life Sciences
Lymphoma
Natural Killer Cell
Breakthrough Therapy
CD19
- Chimeric Antigen Receptor T Cell
Chimeric Antigen Receptor T Cell (CAR-T) is a type of immunotherapy that uses a patient’s own T cells to fight cancer. The T cells are genetically modified to express a special receptor, called a chimeric antigen receptor (CAR), which is designed to recognize and bind to a specific protein found on the surface of cancer cells. Once the CAR-T cells bind to the cancer cells, they can kill them. CAR-T therapy has been used to treat certain types of blood cancers, such as leukemia and lymphoma, and is being studied for other types of cancer.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles